Quality of Life in Patients Undergoing Surgery or Brachytherapy for Stage II Prostate Cancer
Completed
Conditions studied: Prostate Cancer
In brief
RATIONALE: Quality of life assessment in patients undergoing prostate cancer treatment may help determine the intermediate-term and long-term effects of surgery and brachytherapy. PURPOSE: Randomized clinical trial to study quality of life in patients undergoing radical prostatectomy or brachytherapy for stage II prostate cancer.
Key facts
- Study ID
- NCT00052481
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 500
- Starts
- 2002-09-01
- Expected to finish
- 2004-04-01
- Last updated by the study team
- 2016-07-06
Who can join
Age: any, up to 75. Sex: male. Healthy volunteers: not accepted.
Where it is running
- UCSF Comprehensive Cancer Center — San Francisco, California, United States
- Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
- Holden Comprehensive Cancer Center at University of Iowa — Iowa City, Iowa, United States
- Beth Israel Deaconess Medical Center — Boston, Massachusetts, United States
- Washington University School of Medicine — St Louis, Missouri, United States
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
- James P. Wilmot Cancer Center at University of Rochester Medical Center — Rochester, New York, United States
- Presbyterian Hospital — Charlotte, North Carolina, United States
- Cleveland Clinic Taussig Cancer Center — Cleveland, Ohio, United States
- Fletcher Allen Health Care - Medical Center Campus — Burlington, Vermont, United States
- Sentara Norfolk General Hospital — Norfolk, Virginia, United States
- University Cancer Center at University of Washington Medical Center — Seattle, Washington, United States
- Madigan Army Medical Center — Tacoma, Washington, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.